Hans Bunschoten
Chief Operating Officer at ViroClinics Biosciences BV
Hans Bunschoten active positions
Companies | Position | Start | End |
---|---|---|---|
ViroClinics Biosciences BV
ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Chief Operating Officer | 2007-12-31 | - |
Career history of Hans Bunschoten
Former positions of Hans Bunschoten
Companies | Position | Start | End |
---|---|---|---|
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Corporate Officer/Principal | - | - |
Training of Hans Bunschoten
University of Utrecht | Doctorate Degree |
Statistics
International
Netherlands | 4 |
Operational
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
ViroClinics Biosciences BV
ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Health Technology |
Organon BioSciences NV
Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Hans Bunschoten
- Experience